Neuromuscular Cardiomyopathies
Fig. 12.1 Dystrophin gene and protein. (a) The 79 exons of the full-length dystrophin gene with promoters for the alternatively spliced isoforms with red arrows and boxes specific for each…
Fig. 12.1 Dystrophin gene and protein. (a) The 79 exons of the full-length dystrophin gene with promoters for the alternatively spliced isoforms with red arrows and boxes specific for each…
1. Positive prospective crossmatch 2. Irreversible pulmonary hypertension (PVR ≥ 5 Wood units) 3. Malignancy 4. Uncontrolled active systemic infection 5. Severe obstructive or restrictive lung disease 6. Coexisting systemic…
Fig. 1.1 Twenty-six signs all drawn in the same style but compiled from 146 prehistoric sites in France covering 25,000 years—from 35,000 to 10,000 B.C. These symbols may represent a…
Fig. 23.1 Differential regenerative capacity of model organisms. The differential capacity of cardiac regeneration is schematized in the adult human, neonatal mouse, and zebrafish. Top panel outlines the typical response…
Fig. 18.1 The basic mechanism of negative remodeling and progression to dilated cardiomyopathy in hypertension Therefore, it is plausible to hypothesize that hypertensive cardiomyopathy is a preventable disease, at least…
Fig. 5.1 (a). Hypertrophic cardiomyopathy . Left ventricular outflow tract view showing marked left ventricular hypertrophy, outflow tract obstruction, and systolic anterior motion lesion. (b) Closer view of systolic anterior…
Fig. 22.1 VAD support for the patient with end-stage heart failure . Three-dimensional computed tomography thoracic scan demonstrating the HeartMate II and its inflow cannula, pump, and outflow cannula All…
Approach Availabilitya Costb Immune barrierc Infectious barrierd Global availabilitye Allotransplant * ** *** **** *** Assist device *** ** ** ** ** Artificial heart ** ** ** *** ** Engineeringf…
Fig. 24.1 Distinct differences are observed between pluripotent (a) and multipotent (b) stem cell populations. Schematic highlighting the major differences between pluripotent (i.e., ESC and hiPSC) versus multipotent (i.e., myogenic…
Fig. 19.1 (a) ECG exhibiting polymorphous VT that was determined to be torsades de pointes, (b) ECG showing sustained scar-related monomorphic VT. ECG electrocardiogram, VT ventricular tachycardia Apart from acute…